Skip to content
Patients & Caregivers
Diseases & Disorders
Report an Adverse Event
Healthcare Professionals
Global Research
Responsibility
Health
Education
Environment
Career
Grow With Kaizen
Life at Kaizen
Apply Now
About Kaizen
Global
Global Presence
Partner With Us
Therapeutic Areas
Oncology
Hematology
Nephrology
Neuroscience
Cardiology
Dentistry
Orthopedics
Gastroenterology
Gynecology
Respiratory
Products
Science & Research
Our Approach
Oncology Excellence
Operational Excellence
Quality & Compliance
Supply Chain
Digital Transformation
Business Development
News & Media
News
Articles
Podcasts
Contact Us
Language
EN
English
EN
Urdu
UR
Arabic
AR
Patients & Caregivers
Diseases & Disorders
Report an Adverse Event
Healthcare Professionals
Global Research
Responsibility
Health
Education
Environment
Career
Grow With Kaizen
Life at Kaizen
Apply Now
Explore
About Kaizen
Global
Global Presence
Partner With Us
Therapeutic Areas
Therapeutic Areas
Oncology
Hematology
Nephrology
Neuroscience
Cardiology
Dentistry
Orthopedics
Gastroenterology
Gynecology
Respiratory
Products
Science & Research
Our Approach
Oncology Excellence
Operational Excellence
Quality & Compliance
Supply Chain
Digital Transformation
Business Development
News & Media
News
Articles
Podcasts
Contact Us
M
Muflex Pro
Generic Name
CARBOCISTEINE + PROMETHAZINE HCL
Therapeutic Area
Respiratory
Therapeutic Class
Expectorant/mucolytics
Dosage Form
Syrup
Strength
100 mg, 2.5 mg & 120 ml
Pack Size
120 ml
Registration Number
73898
Prescribing Information
→
Overview
Supplied as:
Syrup: 100MG+ 2.5MG, 120ml
Indication
Dry cough particularly nocturnal Adjuvant upper respiratory tract infections
Related products
Muflex
Myaller
Myaller
P
Proact